Akebia Therapeutics, Inc.
AKBA
$3.25
$0.06472.03%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 247.62% | 170.19% | 20.84% | -26.89% | -26.27% |
Total Receivables | 144.61% | 131.17% | -12.53% | 42.40% | 52.08% |
Inventory | -30.01% | -22.72% | 3.52% | 11.12% | 14.19% |
Prepaid Expenses | -- | -91.29% | -72.19% | -62.82% | -46.39% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 6.86% | 64.49% | 27.23% | 138.88% | 171.44% |
Total Current Assets | 109.33% | 80.43% | -3.65% | -8.65% | -5.36% |
|
|||||
Total Current Assets | 109.33% | 80.43% | -3.65% | -8.65% | -5.36% |
Net Property, Plant & Equipment | -41.90% | -38.50% | -35.07% | -32.14% | -29.53% |
Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Intangibles | -- | -- | -100.00% | -80.00% | -66.67% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 148.57% | 225.12% | 200.87% | 602.59% | 431.03% |
Total Assets | 56.95% | 37.57% | -8.70% | -11.85% | -13.21% |
|
|||||
Total Accounts Payable | 14.32% | 6.53% | 3.72% | 49.30% | -14.17% |
Total Accrued Expenses | 117.17% | 48.62% | -22.52% | -34.83% | -35.49% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 147.46% | 91.83% | -59.59% | -41.50% | -74.99% |
Total Finance Division Other Current Liabilities | -51.85% | 21.48% | 24.61% | 13.36% | 565.19% |
Total Other Current Liabilities | -51.85% | 21.48% | 24.61% | 13.36% | 565.19% |
Total Current Liabilities | 10.64% | 37.21% | -18.98% | -17.56% | 16.40% |
|
|||||
Total Current Liabilities | 10.64% | 37.21% | -18.98% | -17.56% | 16.40% |
Long-Term Debt | 94.69% | 115.10% | 57.67% | 0.07% | 21.45% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -89.35% | -72.20% | -60.36% | -51.73% | -45.13% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -60.27% | -87.01% | -80.98% | 2.50% | -51.66% |
Total Liabilities | 24.58% | 13.01% | -0.89% | -6.15% | -9.47% |
|
|||||
Common Stock & APIC | 6.21% | 6.07% | 3.22% | 2.23% | 2.14% |
Retained Earnings | -2.23% | -2.79% | -4.31% | -2.86% | -2.54% |
Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Common Equity | 186.58% | 190.18% | -60.82% | -27.85% | -25.91% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 186.58% | 190.18% | -60.82% | -27.85% | -25.91% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 186.58% | 190.18% | -60.82% | -27.85% | -25.91% |
|